| Michele L North, APRN-CNM | |
|
717 N 190th Plz, Ste. 1500, Elkhorn, NE 68022-3913 | |
| (402) 815-1700 | |
| Not Available |
| Full Name | Michele L North |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 717 N 190th Plz, Elkhorn, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386936326 | NPI | - | NPPES |
| 10025889900 | Medicaid | NE | |
| 47068731799 | Medicaid | NE | |
| 1386396326 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 120045 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michele L North, APRN-CNM Po Box 3755, Omaha, NE 68103-0755 Ph: () - | Michele L North, APRN-CNM 717 N 190th Plz, Ste. 1500, Elkhorn, NE 68022-3913 Ph: (402) 815-1700 |
News Archive
Gerald Barnes, 70, was sentenced on his fifth conviction of impersonating a doctor. The 10-year sentence imposed by United States District Judge J. Spencer Letts in Los Angeles will run consecutive to both the 12½-year sentence and a separate, previously imposed 2½-year sentence for the escape. The prior sentences are not due to expire until June 2009.
With India now having endured six months of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there are now over 410,000 official cases in and more than 13,000 deaths recorded. Almost all these deaths have occurred in the last three months, April to June, with 100 deaths on April 4, 2020, increasing almost 16-fold by May 4, and 63-fold by June 4, 2020.
Even a modest one percent reduction in mortality from cancer would be worth nearly $500 billion in social value, according to a new study by economists Kevin Murphy and Robert Topel of the University of Chicago Graduate School of Business.
Axovant Sciences Ltd., a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced the first patients screened in MINDSET, a confirmatory global phase 3 study of Axovant's lead product candidate, RVT-101. Axovant also announced that the company and the U.S. Food and Drug Administration have agreed to a Special Protocol Assessment (SPA) supporting this phase 3 program.
› Verified 8 days ago
Katelyn S Schweitzer, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 20611 U Ct Apt 5308, Elkhorn, NE 68022 Phone: 402-616-7855 |